Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,642 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer.
Seber ES, Iriagac Y, Cavdar E, Karaboyun K, Avci O, Yolcu A, Gurdal SO, Oznur M, Ekinci F, Aytac A, Gulturk I, Yilmaz M, Sever N, Kapagan T, Ferhatoglu F, Kahvecioglu FA, Hacibekiroglu I. Seber ES, et al. Among authors: yilmaz m. J Coll Physicians Surg Pak. 2024 Jan;34(1):37-41. doi: 10.29271/jcpsp.2024.01.37. J Coll Physicians Surg Pak. 2024. PMID: 38185958
Ribociclib induced acute kidney injury: A case report.
Gulturk I, Yilmaz M, Ozmen A, Tacar SY, Erdal GS, Tural D. Gulturk I, et al. Among authors: yilmaz m. J Oncol Pharm Pract. 2021 Dec;27(8):2023-2026. doi: 10.1177/10781552211007202. Epub 2021 Apr 13. J Oncol Pharm Pract. 2021. PMID: 33847193
Nivolumab induced hypophysitis in an advanced RCC patient.
Korkmaz Yilmaz M, Gulturk I, Tacar SY, Yilmaz M. Korkmaz Yilmaz M, et al. Among authors: yilmaz m. J Oncol Pharm Pract. 2022 Apr;28(3):759-762. doi: 10.1177/10781552211072212. Epub 2022 Jan 10. J Oncol Pharm Pract. 2022. PMID: 35006033
Lutetium-Associated Myopathy: A Case Report.
Gulturk I, Sonmezoz GB, Yilmaz M, Tacar SY, Ozmen A, Erdal GS, Nalbant MO, Tural D. Gulturk I, et al. Among authors: yilmaz m. Am J Ther. 2024 Jan-Feb 01;31(1):e81-e84. doi: 10.1097/MJT.0000000000001491. Epub 2022 Mar 24. Am J Ther. 2024. PMID: 35383588 No abstract available.
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Özdemir Ö, Zengel B, Yildiz Y, Uluç BO, Cabuk D, Ozden E, Salim DK, Paydas S, Demir A, Diker O, Pilanci KN, Sönmez ÖU, Vatansever S, Dogan I, Gulmez A, Cakar B, Gursoy P, Yildirim ME, Ayhan M, Karadurmus N, Aykan MB, Cevik GT, Sakalar T, Hacibekiroglu I, Gülbagci BB, Dincer M, Garbioglu DB, Kemal Y, Nayir E, Taskaynatan H, Yilmaz M, Avci O, Sari M, Coban E, Atci MM, Esen SA, Telli TA, Karatas F, Inal A, Demir H, Kalkan NO, Yilmaz C, Tasli F, Alacacioglu A. Özdemir Ö, et al. Among authors: yilmaz m, yilmaz c. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310. Epub 2022 Jun 20. Anticancer Drugs. 2022. PMID: 35703239
3,642 results